Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways. [electronic resource]
- Oncogene Mar 2003
- 1281-93 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0950-9232
10.1038/sj.onc.1206261 doi
Animals Apoptosis--drug effects Apoptosis Regulatory Proteins Bcl-2-Like Protein 11 Butadienes--pharmacology Carrier Proteins--biosynthesis Cell Line--drug effects Chromones--pharmacology Cricetinae Cricetulus Culture Media, Serum-Free--pharmacology Cycloheximide--pharmacology Cysteine Endopeptidases--pharmacology Cysteine Proteinase Inhibitors--pharmacology Dactinomycin--pharmacology Enzyme Activation--drug effects Enzyme Inhibitors--pharmacology Fibroblasts--metabolism JNK Mitogen-Activated Protein Kinases Lung Membrane Proteins Mitogen-Activated Protein Kinase 1--antagonists & inhibitors Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinases--antagonists & inhibitors Morpholines--pharmacology Nitriles--pharmacology Nucleic Acid Synthesis Inhibitors--pharmacology Phosphatidylinositol 3-Kinases--physiology Phosphoinositide-3 Kinase Inhibitors Protein Serine-Threonine Kinases--genetics Protein Structure, Tertiary Protein Synthesis Inhibitors--pharmacology Proto-Oncogene Proteins--metabolism Proto-Oncogene Proteins c-bcl-2 Proto-Oncogene Proteins c-raf--genetics RNA, Messenger--biosynthesis Recombinant Fusion Proteins--metabolism Signal Transduction--drug effects bcl-2-Associated X Protein